Evidence map›Paper›PMID 33370393›Full record

SynthesisPloS one2020

Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.

Danielle Rice, Kimberly Corace, Dianna Wolfe, Leila Esmaeilisaraji, Alan Michaud, Alicia Grima, Bradley Austin, Reuben Douma, Pauline Barbeau, Claire Butler and 11 more

Open access · goldAbstract readComparative StudyNetwork Meta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 6 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 6 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  3. Management of opioid use disorder: 2024 update to the national clinical practice guideline.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Psychotherapies in opioid use disorder: toward a step-care model.Journal of neural transmission (Vienna, Austria : 1996) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Danielle RiceOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-5615-7005
Kimberly CoraceOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Dianna WolfeOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-1807-6647
Leila EsmaeilisarajiOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0002-6096-267X
Alan MichaudOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-9217-7361
Alicia GrimaOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Bradley AustinOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Reuben DoumaOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Pauline BarbeauOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Claire ButlerOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Melanie WillowsSubstance Use and Concurrent Disorders Program, The Royal Ottawa Mental Health Centre, Ottawa, Ontario Canada.
Patricia A PoulinOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Beth A SprouleDepartment of Pharmacy, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Amy PorathCanadian Center on Substance Use and Addiction, Ottawa, Ontario, Canada.
Gary GarberOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Sheena TahaCanadian Center on Substance Use and Addiction, Ottawa, Ontario, Canada.
Gord GarnerThe Community Addictions Peer Support Association (CAPSA), Ottawa, Ontario, Canada.
Becky SkidmoreOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
David MoherOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0003-2434-4206
Kednapa ThavornOttawa Hospital Research Institute, Ottawa, Ontario, Canada.
Brian HuttonOttawa Hospital Research Institute, Ottawa, Ontario, Canada.ORCID 0000-0001-5662-8647
Ottawa Hospital · CAUniversity of Ottawa · CACanadian Centre on Substance Use and Addiction · CACentre for Addiction and Mental Health · CA

Funding

CIHR 397976
6 · The paper itself

Abstract

backgroundGuidelines recommend that individuals with opioid use disorder (OUD) receive pharmacological and psychosocial interventions; however, the most appropriate psychosocial intervention is not known. In collaboration with people with lived experience, clinicians, and policy makers, we sought to assess the relative benefits of psychosocial interventions as an adjunct to opioid agonist therapy (OAT) among persons with OUD.

methodsA review protocol was registered a priori (CRD42018090761), and a comprehensive search for randomized controlled trials (RCT) was conducted from database inception to June 2020 in MEDLINE, Embase, PsycINFO and the Cochrane Central Register of Controlled Trials. Established methods for study selection and data extraction were used. Primary outcomes were treatment retention and opioid use (measured by urinalysis for opioid use and opioid abstinence outcomes). Odds ratios were estimated using network meta-analyses (NMA) as appropriate based on available evidence, and in remaining cases alternative approaches to synthesis were used.

resultsSeventy-two RCTs met the inclusion criteria. Risk of bias evaluations commonly identified study limitations and poor reporting with regard to methods used for allocation concealment and selective outcome reporting. Due to inconsistency in reporting of outcome measures, only 48 RCTs (20 unique interventions, 5,404 participants) were included for NMA of treatment retention, where statistically significant differences were found when psychosocial interventions were used as an adjunct to OAT as compared to OAT-only. The addition of rewards-based interventions such as contingency management (alone or with community reinforcement approach) to OAT was superior to OAT-only. Few statistically significant differences between psychosocial interventions were identified among any other pairwise comparisons. Heterogeneity in reporting formats precluded an NMA for opioid use. A structured synthesis was undertaken for the remaining outcomes which included opioid use (n = 18 studies) and opioid abstinence (n = 35 studies), where the majority of studies found no significant difference between OAT plus psychosocial interventions as compared to OAT-only.

conclusionsThis systematic review offers a comprehensive synthesis of the available evidence and the limitations of current trials of psychosocial interventions applied as an adjunct to OAT for OUD. Clinicians and health services may wish to consider integrating contingency management in addition to OAT for OUD in their settings to improve treatment retention. Aside from treatment retention, few differences were consistently found between psychosocial interventions adjunctive to OAT and OAT-only. There is a need for high-quality RCTs to establish more definitive conclusions.

trial registrationPROSPERO registration CRD42018090761.

Indexed as

Analgesics, OpioidOpioid-Related DisordersPsychosocial InterventionCombined Modality TherapyHumansPractice Guidelines as TopicRandomized Controlled Trials as TopicTreatment OutcomeAnalgesics, Opioid

Identifiers

PMID33370393
PMCPMC7769275
OpenAlexW3114429589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.